Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$1.90 USD
-0.05 (-2.56%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $1.90 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value B Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -3.65 |
EPS Last Quarter | -0.77 |
Last EPS Surprise | -133.33% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -13.98 |
Next Year | -0.25 |
EPS (TTM) | -6.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 195.42M | NA | 1.13B |
# of Estimates | NA | 1 | NA | 1 |
High Estimate | NA | 195.42M | NA | 1.13B |
Low Estimate | NA | 195.42M | NA | 1.13B |
Year ago Sales | 165.10M | 337.90M | 1.05B | NA |
Year over Year Growth Est. | NA | -42.17% | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.65 | -5.15 | -13.98 | -0.25 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -3.65 | -5.15 | -13.98 | -0.25 |
Low Estimate | -3.65 | -5.15 | -13.98 | -0.25 |
Year ago EPS | -3.17 | -1.06 | -6.23 | -13.98 |
Year over Year Growth Est. | -15.14% | -385.85% | -124.40% | 98.21% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.65 | -5.15 | -13.98 | -0.25 |
7 Days Ago | -3.65 | -5.15 | -13.98 | -0.25 |
30 Days Ago | -0.41 | -0.86 | 2.51 | 3.67 |
60 Days Ago | -0.41 | -0.86 | 2.51 | 3.67 |
90 Days Ago | -0.76 | -0.04 | 2.31 | 4.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.65 | -5.15 | -13.98 | -0.25 |
Zacks Consensus Estimate | -3.65 | -5.15 | -13.98 | -0.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.77 | -1.44 | -1.06 | -3.17 | NA |
Estimate | -0.33 | -0.12 | -0.98 | -1.67 | NA |
Difference | -0.44 | -1.32 | -0.08 | -1.50 | -0.84 |
Surprise | -133.33% | -1,100.00% | -8.16% | -89.82% | -332.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more